1176995
l 2002
EP
l 2002
EP
601. A TISSUE ENGINEERING SCAFFOLD
Abstract
Year: 2002 Country: EP Doc No: 1176995 For more information visit espacenet.com Read more...
growth factors
621 results in this category
2001020086
l 2001
US
l 2001
US
602. Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins
Abstract
Disclosed are materials that may be used in the design of improved devices and wound treatment platforms though covalent and/or non-covalent attachment of bioactive proteins....
6331422
l 2001
US
l 2001
US
603. Enzyme-mediated modification of fibrin for tissue engineering
Abstract
The invention provides fibrin-based, biocompatible materials useful in promoting cell growth, wound healing, and tissue regeneration. These materials are provided as part of several cell...
183522
l 2001
WO
l 2001
WO
604. GROWTH FACTOR MODIFIED PROTEIN MATRICES FOR TISSUE ENGINEERING
Abstract
Proteins are incorporated into protein or polysaccharide matrices for use in tissue repair, regeneration and/or remodeling and/or drug delivery. The proteins can be incorporated so...
1112348
l 2001
EP
l 2001
EP
605. USE OF GROWTH FACTORS AND HORMONES FOR EXPANSION OF MAMMALIAN CELLS AND TISSUE ENGINEERING
Abstract
Year: 2001 Country: EP Doc No: 1112348 For more information visit espacenet.com Read more...
148147
l 2001
WO
l 2001
WO
606. CELL CULTURE MEDIUM CONTAINING GROWTH FACTORS AND L-GLUTAMINE
Abstract
The invention relates to a culture medium for culturing cells, in particular human cells in a process for tissue engineering bone. The medium comprises glucose,...
2407952
l 2001
CA
l 2001
CA
607. GROWTH FACTOR MODIFIED PROTEIN MATRICES FOR TISSUE ENGINEERING
Abstract
Proteins are incorporated into protein or polysaccharide matrices for use in tissue repair, regeneration and/or remodeling and/or drug delivery. The proteins can be incorporated so...
2395271
l 2001
CA
l 2001
CA
608. CELL CULTURE MEDIUM CONTAINING GROWTH FACTORS AND L-GLUTAMINE
Abstract
The invention relates to a culture medium for culturing cells, in particular human cells in a process for tissue engineering bone. The medium comprises glucose,...
4692200
l 2001
AU
l 2001
AU
609. Growth factor modified protein matrices for tissue engineering
Abstract
Year: 2001 Country: AU Doc No: 4692200 For more information visit espacenet.com Read more...
6077987
l 2000
US
l 2000
US
610. Genetic engineering of cells to enhance healing and tissue regeneration
Abstract
A method for enhancing and/or increasing the efficiency of repair of tissues, primarily bone or cartilage, using genetically engineered cells has been developed. In the...
17321
l 2000
WO
l 2000
WO
611. USE OF GROWTH FACTORS AND HORMONES FOR EXPANSION OF MAMMALIAN CELLS AND TISSUE ENGINEERING
Abstract
The present invention provides an improved method for expanding cells for use in tissue engineering. In particular the method provides specific biochemical factors to supplement...
2348426
l 2000
GB
l 2000
GB
612. Enzyme-mediated modification of fibrin for tissue engineering
Abstract
The invention provides fibrin-based, biocompatible materials useful in promoting cell growth, wound healing, and tissue regeneration. These materials are provided as part of several cell...
2344399
l 2000
CA
l 2000
CA
613. USE OF GROWTH FACTORS AND HORMONES FOR EXPANSION OF MAMMALIAN CELLS AND TISSUE ENGINEERING
Abstract
The present invention provides an improved method for expanding cells for us e in tissue engineering. In particular the method provides specific biochemica l factors...
4606700
l 2000
AU
l 2000
AU
614. A tissue engineering scaffold
Abstract
Year: 2000 Country: AU Doc No: 4606700 For more information visit espacenet.com Read more...
9911789
l 1999
WO
l 1999
WO
615. GENETIC ENGINEERING OF CELLS TO ENHANCE HEALING AND TISSUE REGENERATION
Abstract
A method for enhancing and/or increasing the efficiency of repair of tissues, primarily bone or cartilage, using genetically engineered cells has been developed. In the...
9843686
l 1998
WO
l 1998
WO
616. ENZYME-MEDIATED MODIFICATION OF FIBRIN FOR TISSUE ENGINEERING
Abstract
The invention provides fibrin-based, biocompatible materials useful in promoting cell growth, wound healing, and tissue regeneration. These materials are provided as part of several cell...
2307954
l 1998
CA
l 1998
CA
617. ENZYME-MEDICATED MODIFICATION OF FIBRIN FOR TISSUE ENGINEERING
Abstract
The invention provides fibrin-based, biocompatible materials useful in promoting cell growth, wound healing, and tissue regeneration. These materials are provided as part of several cell...
H0920677
l 1997
JP
l 1997
JP
618. WOUND-HEALING AGENT
Abstract
PURPOSE: To obtain a wound-healing agent containing a thrombomodulin-like protein as an active ingredient, having an effect for stimulating the growth or multiplication of cells...
H08104700
l 1996
JP
l 1996
JP
619. THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES CONTAINING RETINAL PIGMENT EPITHELIAL CELL GROWTH FACTOR AS AN ACTIVE INGREDIENT
Abstract
PURPOSE: To provide a therapeutic agent for ophthalmic diseases, which contains retinal pigment epithelial cell growth factor as an active ingredient, thus is useful for...
H0418031
l 1992
JP
l 1992
JP
620. INJURY HEALING PROMOTER
Abstract
PURPOSE:To obtain the title promoter advantageously usable as a pretreating agent for treatment of injury of animal tissue or transplantation of animal tissue by combining...